Literature DB >> 27872003

Primary and Secondary Provoked Vestibulodynia: A Review of Overlapping and Distinct Factors.

Caroline F Pukall1.   

Abstract

INTRODUCTION: A common subtype of vulvodynia is provoked vestibulodynia (PVD), characterized by severe pain upon contact to the vaginal entrance. Some researchers have further delineated the PVD group based on pain onset (primary vs secondary PVD, referred to as PVD1 and PVD2, respectively). AIM: This study aims to review available evidence regarding sociodemographic variables, pain characteristics, medical history and examination findings, quantitative sensory testing, genetic markers, psychosocial/sexual/relationship function, treatment outcome, and brain imaging in women with PVD1 and PVD2.
METHODS: All available data related to PVD1 and PVD2 were reviewed. MAIN OUTCOME MEASURES: There is mixed evidence supporting the assumption that women with PVD1 fare worse on all variables investigated.
RESULTS: The review indicated that although women with PVD1 seem to fare worse on many variables examined (eg, pain severity, genetic markers), many studies also indicated no significant group differences or-less commonly-that women with PVD2 fare worse on some variables (eg, sexual function).
CONCLUSION: Although it has been suggested that different pathophysiologic processes are involved in the development and maintenance of PVD1 and PVD2, the data reviewed were mixed. While most studies indicated that women with PVD1 have higher pain intensity, higher sensitivity, more genetic influence, more evidence of inflammation, lower successful treatment outcomes, and different neural activation patterns and structural findings, these results were not consistently reported. In addition, the data for subgroup differences in psychosocial, sexual, and relationship variables were not convincing. A more precise definition of primary and secondary PVD is needed, and importantly, prospective, longitudinal studies are essential for clarifying any differences within these PVD subgroups.
Copyright © 2016 International Society for Sexual Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Pain Characteristics; Pain Onset; Primary; Secondary; Vestibulodynia; Vulvodynia

Mesh:

Year:  2016        PMID: 27872003     DOI: 10.1016/j.sxmr.2015.10.012

Source DB:  PubMed          Journal:  Sex Med Rev        ISSN: 2050-0521


  6 in total

1.  Early experience with topical meloxicam and lidocaine combination for the treatment of vulvodynia.

Authors:  Rufina Kim; Kerri-Lynn Kelly; Merle Olson; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-04-06       Impact factor: 1.862

Review 2.  Treatment of Vulvodynia: Pharmacological and Non-Pharmacological Approaches.

Authors:  Natalie O Rosen; Samantha J Dawson; Melissa Brooks; Susan Kellogg-Spadt
Journal:  Drugs       Date:  2019-04       Impact factor: 9.546

3.  A mucoadhesive biodissolvable thin film for localized and rapid delivery of lidocaine for the treatment of vestibulodynia.

Authors:  Denali K Dahl; Ashlyn N Whitesell; Preetika Sharma-Huynh; Panita Maturavongsadit; Rima Janusziewicz; Ryan J Fox; Henry T Loznev; Brian Button; Allison N Schorzman; William Zamboni; Jisun Ban; Stephanie A Montgomery; Erin T Carey; S Rahima Benhabbour
Journal:  Int J Pharm       Date:  2021-11-17       Impact factor: 5.875

4.  Disease-Related Microstructural Differences in the Brain in Women With Provoked Vestibulodynia.

Authors:  Arpana Gupta; Davis C Woodworth; Benjamin M Ellingson; Andrea J Rapkin; Bruce Naliboff; Lisa A Kilpatrick; Jean Stains; Salome Masghati; Kirsten Tillisch; Emeran A Mayer; Jennifer S Labus
Journal:  J Pain       Date:  2018-01-31       Impact factor: 5.820

5.  Retrospective Study of the Prevalence and Risk Factors of Clitoral Adhesions: Women's Health Providers Should Routinely Examine the Glans Clitoris.

Authors:  Leen Aerts; Rachel S Rubin; Michael Randazzo; Sue W Goldstein; Irwin Goldstein
Journal:  Sex Med       Date:  2018-03-17       Impact factor: 2.491

Review 6.  Provoked vestibulodynia: current perspectives.

Authors:  Helen Henzell; Karen Berzins; Jennifer P Langford
Journal:  Int J Womens Health       Date:  2017-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.